Patterns of relapse and outcome of elderly multiple myeloma patients treated as front- line therapy with novel agents combinations Aurelio Lopez, Maria-Victoria.

Slides:

Advertisements

Similar presentations

Genetic and Epigenetic Silencing of MicroRNA-203 Enhances ABL1 and BCR-ABL1 Oncogene Expression María J. Bueno, Ignacio Pérez de Castro, Marta Gómez de.

Advertisements

Treatment of HER2 positive advanced breast cancer with T-DM1: A review of the literature María Teresa Martínez, José Alejandro Pérez-Fidalgo, Paloma Martín-Martorell,

Single-Unit Umbilical Cord Blood Transplantation from Unrelated Donors in Adult Patients with Chronic Myelogenous Leukemia Jaime Sanz, Pau Montesinos,

Bortezomib plus melphalan and prednisole in elderly untreated patients with multiple myeloma: results of a multicenter phase 1/2 study Marı´a-Victoria.

Parathyroidectomy: Whom and when?

Single-Unit Umbilical Cord Blood Transplantation from Unrelated Donors in Adult Patients with Chronic Myelogenous Leukemia Jaime Sanz, Pau Montesinos,

Bo Karlsson, Gunilla Burell, Ulla-Maria Anderberg, Kurt Svärdsudd

Volume 144, Issue 1, Pages (January 2017)

Clinical outcomes of AML patients treated with Azacitidine in Portugal: A retrospective multicenter study António Almeida, Ana Rita Ferreira, Maria João.

Combination chemotherapy with bevacizumab and S-1 for elderly patients with metastatic colorectal cancer (BASIC trial) M. Yoshida, K. Muro, A. Tsuji,

A primary esophageal MALT lymphoma patient with Helicobacter pylori infection achieved complete remission after H. pylori eradication without anti-lymphoma.

First-line panitumumab plus FOLFOX4 or FOLFIRI in colorectal cancer with multiple or unresectable liver metastases: A randomised, phase II trial (PLANET-TTD)

Primary Breast Lymphoma: Analysis of 55 Cases of the Spanish Lymphoma Oncology Group Fernando Franco Pérez, Javier Lavernia, David Aguiar-Bujanda, José.

Volume 152, Issue 4, Pages (October 2017)

Survival analysis and correlation study

A double-blind randomized study of aminoglycoside infusion with combined therapy for pulmonary Mycobacterium avium complex disease Yoshihiro Kobashi,

Oncol Res Treat 2016;39: DOI: /

GEIS guidelines for gastrointestinal sarcomas (GIST)

European Urology Focus

Volume 58, Issue 4, Pages (October 2010)

Bloodstream Infections in Adult Patients Undergoing Cord Blood Transplantation from Unrelated Donors after Myeloablative Conditioning Regimen Jaime Sanz,

Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN)‏ by Antonio Palumbo,

Building better therapy for children with acute lymphoblastic leukemia

P2.03b-044 Treatment Outcome and the Role of Primary Tumor Therapy in a Cohort of Patients with Synchronous Oligometastatic NSCLC Jose Carlos Ruffinelli,

Impact on Outcomes of Human Leukocyte Antigen Matching by Allele-Level Typing in Adults with Acute Myeloid Leukemia Undergoing Umbilical Cord Blood Transplantation

Primary Breast Lymphoma: Analysis of 55 Cases of the Spanish Lymphoma Oncology Group Fernando Franco Pérez, Javier Lavernia, David Aguiar-Bujanda, José.

Comparison of popliteal artery aneurysm therapies

Preoperative Pulmonary Rehabilitation Versus Chest Physical Therapy in Patients Undergoing Lung Cancer Resection: A Pilot Randomized Controlled Trial

Volume 56, Issue 1, Pages (July 2009)

Volume 70, Issue 5, Pages (November 2016)

Prognostic Factors of Chronic Graft-versus-Host Disease Following Allogeneic Peripheral Blood Stem Cell Transplantation: The National Institutes Health.

Volume 148, Issue 1, Pages (January 2018)

Allogeneic Stem Cell Transplantation for Relapsed or Refractory Lymphoma after Conditioning with BEAM/Fludarabine/TBI Alix O’Meara, Jörg Halter, Dominik.

Docetaxel Treatment in PTEN- and ERG-aberrant Metastatic Prostate Cancers Pasquale Rescigno, David Lorente, David Dolling, Roberta Ferraldeschi, Daniel.

M. Giannella, B. Pinilla, J. A. Capdevila, J. Martínez Alarcón, P

Application of Self-Quenched JH Consensus Primers for Real-Time Quantitative PCR of IGH Gene to Minimal Residual Disease Evaluation in Multiple Myeloma

Role of conservative management in traumatic aortic injury: Comparison of long-term results of conservative, surgical, and endovascular treatment Victor.

Surgical Results and Prognostic Factors in Early Non–Small Cell Lung Cancer José Padilla, MD, Vı́ctor Calvo, MD, Juan C Peñalver, MD, Gabriel Sales, MD,

Outcomes of Allogeneic Stem Cell Transplantation in Elderly Patients with Acute Myeloid Leukemia: A Systematic Review and Meta-analysis Armin Rashidi,

External quality control for embryology laboratories

Parathyroidectomy: Whom and when?

Roser Coll-Fernández, MD, Ramon Coll, MD, PhD, Teresa Pascual, MD, J

Effect of combining tramadol and morphine in adult surgical patients: a systematic review and meta-analysis of randomized trials V. Martinez, L. Guichard,

Multiple Myeloma in Serologic Complete Remission after Autologous Stem Cell Transplantation: Impact of Bone Marrow Plasma Cell Assessment by Conventional.

Perioperative statin therapy in patients at high risk for cardiovascular morbidity undergoing surgery: a review B.A. de Waal, M.P. Buise, A.A.J. van.

A Mitral Heart Valve Prosthesis Hidden Under Perivalvular Pannus

Intravenous Busulfan and Melphalan as a Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma:

Clinical Lymphoma, Myeloma and Leukemia

Single-Agent Liposomal All-Trans-Retinoic Acid as Initial Therapy for Acute Promyelocytic Leukemia: 13-Year Follow-Up Data Preetesh Jain, Hagop Kantarjian,

Volume 152, Issue 1, Pages (January 2019)

Volume 90, Issue 6, Pages (December 2016)

Prognostic Impact of Serum Immunoglobulin Heavy/Light Chain Ratio in Patients with Multiple Myeloma in Complete Remission after Autologous Stem Cell Transplantation

Matthew J. Bott, MD, Hanghang Wang, BA, William Travis, MD, Gregory J

Volume 67, Pages S63-S68 (January 2005)

Long-term outcomes of metabolic and bariatric surgery in adolescents with severe obesity with a follow-up of at least 5 years: A systematic review Patricia.

Rituximab-Based Chemoimmunotherapy Prolongs Survival of Patients With Chronic Lymphocytic Leukemia Independently of the Time of Administration Julio.

Trabectedin and RAdiotherapy in Soft Tissue Sarcoma (TRASTS): Results of a Phase I Study in Myxoid Liposarcoma from Spanish (GEIS), Italian (ISG), French.

Impact of Autologous Stem Cell Transplantation on the Incidence and Outcome of Oligoclonal Bands in Patients with Light-Chain Amyloidosis Luis Gerardo.

Daratumumab in Combination with Carfilzomib and Dexamethasone in Patients (pts) with Relapsed Multiple Myeloma (MMY1001): An Open-Label, Phase 1b Study.

Second Autologous Stem Cell Transplantation as Salvage Therapy for Multiple Myeloma: Impact on Progression-Free and Overall Survival Victor H. Jimenez-Zepeda,

Kinetics and Risk Factors of Relapse after Allogeneic Stem Cell Transplantation in Children with Leukemia: A Long-Term Follow-Up Single-Center Study

Effect of CD8+ Cell Content on Umbilical Cord Blood Transplantation in Adults with Hematological Malignancies Federico Moscardó, Jaime Sanz, Francisco.

New trials and results in systemic treatment of HCC

Volume 54, Pages S135-S139 (December 1998)

Relapse to prior autograft and chronic graft-versus-host disease are the strongest prognostic factors for outcome of melphalan/fludarabine-based dose-reduced.

Systematic review of the QoR-15 score, a patient- reported outcome measure measuring quality of recovery after surgery and anaesthesia J. Kleif, J. Waage,

Volume 54, Pages S112-S119 (December 1998)

High-dose therapy intensification compared with continued standard chemotherapy in multiple myeloma patients responding to the initial chemotherapy: long-term.

Autologous Stem Cell Transplantation for POEMS Syndrome

Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD

Presentation transcript:

Patterns of relapse and outcome of elderly multiple myeloma patients treated as front- line therapy with novel agents combinations Aurelio Lopez, Maria-Victoria Mateos, Albert Oriol, Marta Valero, Joaquín Martínez, Jose Ignacio Lorenzo, Montserrat Perez, Rafael Martinez, Raquel de Paz, Miguel Granell, Felipe De Arriba, M. Jesús Blanchard, Francisco Javier Peñalver, Jose Luis Bello, Maria Luisa Martin, Joan Bargay, Joan Blade, Juan Jose Lahuerta, Jesús F. San Miguel, Javier de la Rubia Leukemia Research Reports Volume 4, Issue 2, Pages 64-69 (January 2015) DOI: 10.1016/j.lrr.2015.09.002 Copyright © 2015 The Authors Terms and Conditions

Fig. 1 Flow diagram of relapsed patients. Leukemia Research Reports 2015 4, 64-69DOI: (10.1016/j.lrr.2015.09.002) Copyright © 2015 The Authors Terms and Conditions

Fig. 2 Post relapse progression-free survival according to front-line treatment (A) and (B) progression-free survival depending on the type of therapy administered at relapse. Leukemia Research Reports 2015 4, 64-69DOI: (10.1016/j.lrr.2015.09.002) Copyright © 2015 The Authors Terms and Conditions

Fig. 3 Overall survival according to front-line treatment. Leukemia Research Reports 2015 4, 64-69DOI: (10.1016/j.lrr.2015.09.002) Copyright © 2015 The Authors Terms and Conditions

Fig. 4 Overall survival according to the type of response achieved after relapse. Leukemia Research Reports 2015 4, 64-69DOI: (10.1016/j.lrr.2015.09.002) Copyright © 2015 The Authors Terms and Conditions

Fig. 5 Overall survival according to the type of relapse. Leukemia Research Reports 2015 4, 64-69DOI: (10.1016/j.lrr.2015.09.002) Copyright © 2015 The Authors Terms and Conditions